Doctor of Dentistry Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Todd Sawisch

Dentist, Oral and Maxillofacial Pathology Fort Lauderdale, FL Doctor of Dentistry

NPI 1437196847 CMS profile 111009

2161 E Commercial Blvd, Fort Lauderdale, FL 33308

Open in the dashboard

General payments

$447,697

205 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Todd Sawisch of Fort Lauderdale, FL is reported in the CMS Open Payments database as having received $447,697 across 205 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Dentist, Oral and Maxillofacial Pathology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $81,727 16
2024 General $63,943 15
2023 General $49,941 17
2022 General $40,647 34
2021 General $63,121 55
2020 General $50,264 10
2019 General $98,055 58

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Todd Sawisch
  • Dentist, Oral and Maxillofacial Pathology median
  • Middle half of Dentist, Oral and Maxillofacial Pathology
  • National median

In program year 2025, general payments to Todd Sawisch were reported at $81,727. Among 128 Dentist, Oral and Maxillofacial Pathology profiles paid that year, the median was $91 and the middle half received between $35 and $330.

Show as a table
Year Todd Sawisch Dentist, Oral and Maxillofacial Pathology median Middle half National median
2019 $98,055 $106 $28–$326 $163
2020 $50,264 $109 $33–$500 $114
2021 $63,121 $104 $30–$557 $132
2022 $40,647 $104 $37–$432 $149
2023 $49,941 $152 $41–$372 $160
2024 $63,943 $100 $38–$354 $164
2025 $81,727 $91 $35–$330 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Implant Direct Sybron International LLC $301,383 160 payments
  2. Envista Holdings Corporation $145,485 28 payments
  3. Dentsply Sirona Inc $285 8 payments
  4. Nobel Biocare USA $260 2 payments
  5. DePuy Synthes Sales Inc. $140 1 payment
  6. Neoss, Inc. $59 2 payments
  7. Allergan Inc. $40 2 payments
  8. Merz North America, Inc. $30 1 payment
  9. BioHorizons Implant Systems Inc. $15 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for serving as faculty or as a speaker for a medical education program $247,465 45 payments
  2. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $129,200 19 payments
  3. Travel and Lodging $57,590 101 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $7,500 1 payment
  5. Food and Beverage $5,942 39 payments
Products named General payments · program years 2019–2025
  1. EDUCATION $428,141 182 payments
  2. NOT RELATED TO ANY PRODUCT $18,564 4 payments
  3. NOBELACTIVE $260 2 payments
  4. TRUMATCH $140 1 payment
  5. LEGACY SYSTEM $125 1 payment
  6. Implant Dentistry $103 1 payment
  7. ASTRA TECH Implant System $96 3 payments
  8. Neoss ProActive Implant Systems $59 2 payments
  9. Consumable Dentistry $50 3 payments
  10. INTERACTIVE SYSTEM $38 1 payment
  11. Other $90 4 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 10 drugs

Part D claims

409

Median for Dentist: 47

Drug cost

$2,016

Median for Dentist: $159

Branded share of claims

8.6%

Median for Dentist: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Chlorhexidine Gluconate Generic 155 $681
Amoxicillin Generic 122 $500
Ketorolac Tromethamine Generic 14 $186
Metronidazole Generic 32 $177
Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav Brand 21 $164
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 14 $98
Clindamycin Hcl Generic 15 $89
Methylprednisolone Generic 14 $52
Levofloxacin Generic 11 $48
Ibuprofen Generic 11 $22

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 110,731 Part D prescribers listed as Dentist; they describe a distribution and say nothing about conduct.

Records

205 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Dentist, Oral and Maxillofacial Pathology in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record